For biotech and pharma, the catalysts we’re interested in are clinical trial updates and results and the big money-maker—an FDA approval.
💥 FDA Catalyst News: www.biopharmcatalyst.com/calendars/pdufa-calendar
This website is one of a few reliable ones and also one of my favorites.
PDUFA dates are deadlines for the FDA to review new drugs. The FDA is normally given 10 months to review new drugs. If a drug is selected for priority review, the FDA is allotted 6 months to review the drug. These time frames begin on the date that an NDA is accepted by the FDA as complete.